Efficacy, safety, and genetic analysis of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small-cell lung cancer: a phase 2b, multicentre, single-arm, open-label study

Yuankai Shi, Xingsheng Hu, Shucai Zhang, Dongqing Lv, Lin Wu, Qitao Yu, Yiping Zhang, Li Liu, Xiang Wang, Ying Cheng, Zhiyong Ma, Hongrui Niu, Dong Wang, Jifeng Feng, Cheng Huang, Chunling Liu, Hui Zhao, Jingzhang Li, Xiaodong Zhang, Yong Jiang, Chuan Gu